Zeleciment rostudirsen

N/A

Report date: 2026/05/21 09:33:28

Base Information

Drug NameZeleciment rostudirsen

Drug Alias NameDYNE-251 (consists of a phosphorodiamidate morpholino oligomer (PMO) conjugated to a fragment antibody (Fab))Z-rostudirsenDYNE251

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate

Mechanisms of ActionDystrophin expression stimulantsAnti-Transferrin receptor protein 1

TargetsTransferrin receptor protein 1Dystrophin

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumCanadaUnited States +[9]

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesDyne Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesDyne Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A